Portrait Reinhard Zeidler

STB,

How to found a biomedical start-up?

An interview with Prof. Reinhard Zeidler

spliceosome assembly

Awards & Grants, STB,

Unleashing splicing to understand biology and eventually tackle ‘untreatable’ diseases

Cells use editing tools to skip or rearrange information stored in DNA. Thanks to a 10-million-euro ERC Synergy Grant co-financed by ERC and UKRI, researchers have launched a new project to study how this machinery can be controlled with molecular…

Portrait Reinhard Zeidler

Transfer, STB,

Targeted Antibody Therapy Against Brain Tumor Glioblastoma

Prof. Reinhard Zeidler about hope in the fight against glioblastoma, the most common and malignant form of brain tumor and how he accelerates the development of antibodies into application.

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, STB,

Structural basis of metabolite transport by the chloroplast outer envelope channel OEP21

Triose phosphates (TPs) are the primary products of photosynthetic CO2 fixation in chloroplasts, which need to be exported into the cytosol across the chloroplast inner envelope (IE) and outer envelope (OE) membranes to sustain plant growth.

A team…

3D model Chagas protein blocking molecule

Transfer, Awards & Grants, Molecular Targets and Therapeutics, STB,

Helmholtz Zentrum München Is the Recipient of the 2020 Erwin Schrödinger Prize

Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…

AI with young man in the night

Molecular Targets and Therapeutics, STB,

Artificial Intelligence (AI) And Machine Learning Are Revolutionizing the Way New Drugs Are Designed

Helmholtz Zentrum München is coordinating a European network to train the next generation of researchers in drug development.